How Does RAD51C Mutation Affect Treatment Options?
Knowing a patient has a RAD51C mutation can influence treatment decisions. For instance, patients may benefit from targeted therapies, such as PARP inhibitors, which are particularly effective in cancers associated with homologous recombination repair deficiencies. This personalized approach can improve outcomes and reduce unnecessary treatments.
